Research presented at the Society for Behavioral Medicine’s Annual Meeting furthers Omada’s robust body of evidence, highlighting the potential of personalized care paths to improve program engagement ...

Medicaid/CHIP surveillance demonstrated an 11.4% relative rise in pediatric diabetes prevalence, including a 24.3% increase in type 2 diabetes, with disparities by geography, sex, and region.

Providers treating chronic disease have always grappled with a fundamental disconnect that, in many cases, is considered unavoidable. The most critical determinants of a patient’s health — such as ...

Behavior change in health is challenging. Most consumers seek simple, effortless strategies to achieve their health goals without significant investments of time, energy or mental bandwidth. They're ...

New analysis adds to existing evidence that Omada’s program paired with GLP-1 medications leads to greater weight loss and persistence than reported in real world evidence SAN FRANCISCO, Jan. 08, 2026 ...

What do a former smoker, a successful entrepreneur, and a champion athlete have in common? They’ve all mastered the art of iteration—the key to lasting behavior change. In a world of constant flux and ...

With the launch of a revamped 4.0 version of its flagship app, WebMD has begun to execute on a strategy that Bill Pence, the company's EVP and CTO, laid out for MobiHealthNews earlier this year. Based ...

This episode recorded live at the Becker’s 16th Annual Meeting features Jennifer Jones, Director of Clinical Solutions, Noom. Here, she explores how GLP-1s should be viewed as part of chronic disease ...

"In the province of the mind, what one believes to be true either is true or becomes true within certain limits, to be found experientially and experimentally. These limits are beliefs to be ...

During the pandemic, arming the C-suite with employee data was never more critical. Executives needed insights on employee health, well-being and sentiment to make fast decisions since working ...